Username
Password
Home
Forgotten Password?
Register Now
Site Map
Advertising
THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET
Search:
Advanced Search
This channel:
Outsourced Services
>
Contract-Manufacturing
Most popular article in
Contract Manufacturing
Xamiol (R) - LEO Pharma's new drug for the treatment of scalp psoriasis - is approved in Europe
More in detail
Company
:
LEO Pharma
Date Published
:
19/08/2008
Articles in
Contract Manufacturing:
Select to view sub-categories of this category
View All
Blending
Contract Manufacturing
Filling
Lyophilisation
Packaging
Regulatory affairs
Subject
Contributor
Date Published
ReGen Biologics collagen scaffold receives positive orthopaedic panel recommendations
ReGen Biologics, Inc
19/11/2008
The CEO of Wyatt Technology receives 2009 American Physical Society Prize for Industrial Application of Physics
Wyatt Technology
18/11/2008
Gilead Sciences announces notification of ANDA filing for Truvada
Gilead Sciences, Inc
14/11/2008
Delphi Genetics and Eurogentec biologics collaborate for antibiotic resistance-gene free GMP manufacturing
Delphi Genetics SA
13/11/2008
Delphi Genetics and Eurogentec biologics collaborate for antibiotic resistance-gene free GMP manufacturing
Eurogentec
13/11/2008
Gene Signal Enters Phase III Clinical Tests For The Prevention Of Corneal Graft Rejection
Gene Signal International
10/11/2008
Biogen Idec elects to participate with Genentech in the development and commercialization of a next generation anti-CD20 molecule
Biogen Idec
31/10/2008
Innexus Biotechnology receives patent grants in Europe
InNexus Biotechnology Inc.
30/10/2008
Therapure BioPharma Inc. announces collaboration with Induce Biologics Inc.
Therapure Biopharma Inc
28/10/2008
Laureate Pharma announces agreement with Tolera Therapeutics, Inc.
Laureate Pharma, Inc.
28/10/2008
Phase 3 data indicate investigational 13-valent vaccine may broaden protection against pneumoccocal disease in children younger than two
Wyeth
27/10/2008
GLAXOSMITHKLINE AND AFFIRIS SIGN AN EXCLUSIVE LICENCE AND OPTION AGREEMENT FOR THERAPEUTIC ALZHEIMER'S DISEASE CANDIDATE VACCINES
PR&D - Public Relations for Research and Education
24/10/2008
Phase IIb data published in the lancet show that bg-12, Biogen Idec's novel oral compound, significantly reduced brain lesions in patients with multiple sclerosis
Biogen Idec
24/10/2008
Laureate announces manufacturing agreement with Tolerx
Laureate Pharma, Inc.
22/10/2008
Spanish acquisition for Presspart
Presspart
07/10/2008
Grifols breaks ground on new IVIG facility
Grifols SA
06/10/2008
ITGI Medical received a CE mark for its second pericardium covered stent - AneuGraft(R) - for tortuous vessels
ITGI Medical, Ltd
30/09/2008
Boston Scientific celebrates grand opening of international institute for therapy advancement
Boston Scientific Corporation
26/09/2008
LEO Pharma unveils major breakthrough in psoriasis management
LEO Pharma
22/09/2008
Laureate Pharma to add more manufacturing capacity
Laureate Pharma, Inc.
18/09/2008
First
Previous
1 to 20 of 382
Next
Last
© CMP information Ltd 2007
Terms and Conditions
Privacy Policy
